Tenderwize
Zurück zur Suche

Open-house rebate agreements for Betamethason and antibiotics

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Betamethason und Antibiotika, ATC D07CC01

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

46 / 100

Komplexität

58 / 100

Risikofaktoren

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive rebate agreements for pharmaceutical products with active substance Betamethason and antibiotics, ATC D07CC01.
  • Open-house model with uniform terms for all participants; no individual negotiations.
Vollständige Zusammenfassung anzeigen

This is an open-house pharmaceutical supply notice by AOK Rheinland-Pfalz/Saarland for non-exclusive rebate agreements on Betamethason and antibiotics (ATC D07CC01), with a 24-month maximum term and monthly entry possible. The notice explicitly states that it is not a public procurement contract under the procurement rules, but it is published for transparency. No contract value is provided. Submission is by original documents only; electronic submission is not allowed. The notice excludes medicines listed as children’s medicines under the BfArM list (§ 35 Abs. 5a SGB V).

Risiken

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Only authorised and marketable medicines in Germany may be supplied.

Administrative

  • If a medicine is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided with the required information.
  • If the AMIce extract is incomplete or outdated, supplementary evidence such as approval documents, change notifications, or an affidavit must be submitted.

Auftraggeber

Lose (1)

LOT-0001

Open-house rebate agreements for Betamethason and antibiotics

Single lot open-house model for non-exclusive rebate agreements for medicines with the stated active substance/ATC D07CC01. The contracting buyer offers the same conditions to all interested pharmaceutical companies, with no individual negotiations. Contracts can start on the first day of each month within the 24-month period, earliest 2025-06-01, and end no later than 24 months after the earliest start date. The notice says the buyer may replace these open-house agreements with exclusive agreements later. Medicines listed as children’s medicines under the BfArM list are excluded. Eligibility-related supply proof is required for marketed medicines in Germany.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
237226-2025

Dokumente (1)

Ähnliche Ausschreibungen